Drugs / ZOC2017217
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07395986 | Feb 2026 → Mar 2027 expected | cataract | Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZOC2017217 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07395986 ↗ |